BVA decisions by condition

Ulcerative colitis: BVA grant rates and what wins

From 2018 to 2026, the Board of Veterans' Appeals decided a ulcerative colitis issue in 1,130 decisions. It granted the ulcerative colitis issue in 22.4% of them, above the 19.9% grant rate for all conditions, denied it in 28.1%, and remanded it in 47.6%. Counting only decisions on the merits (granted or denied), 44.4% were granted.

Decisions

1,130

2018–2026

Granted

22.4%

All conditions: 19.9%

Granted on the merits

44.4%

Granted ÷ (granted + denied)

Remanded

47.6%

Denied: 28.1%

Ulcerative colitis outcomes by year

YearDecisionsGrantedDeniedRemanded
2018
130
10.0%37.7%51.5%
2019
159
17.6%29.6%49.1%
2020
127
22.8%39.4%38.6%
2021
131
22.9%27.5%47.3%
2022
124
22.6%29.0%47.6%
2023
142
26.8%20.4%48.6%
2024
126
25.4%22.2%50.8%
2025
139
30.9%23.7%43.2%
2026
52
23.1%17.3%57.7%

Evidence in granted and denied ulcerative colitis decisions

For each kind of supporting evidence: how often the Board granted the ulcerative colitis issue on the merits when the decision mentioned it, compared with decisions that did not. These are associations, not causes, and evidence is recorded per decision, not per issue.

In the recordDecisionsGranted when presentWhen absentDifference
Treating physician opinion11576.1%38.6%+37.5 pts
Positive nexus opinion18568.8%37.5%+31.3 pts
Favorable VA exam13765.3%39.9%+25.5 pts
Private medical opinion38456.3%35.3%+21.0 pts
Combat service6350.0%44.1%+5.9 pts
Lay statement88744.9%41.2%+3.8 pts
Claimed as secondary19647.1%44.0%+3.0 pts
  • The Board applied the benefit-of-the-doubt rule (38 CFR 3.102) in 72.3% of the decisions that granted ulcerative colitis.
  • The Board found the veteran's statements credible in 37.2% of grants and 14.2% of denials.

Negative evidence in the record

An unfavorable exam or a negative nexus opinion often sits in the same record as favorable evidence, and the Board weighs them against each other. So these rows show how often ulcerative colitis was still granted when the record contained the negative item, not that the item helped.

In the recordDecisionsGranted when presentWhen absentDifference
Negative nexus opinion56340.0%49.4%−9.4 pts
Unfavorable VA exam81741.1%57.5%−16.4 pts

Why the Board granted or denied ulcerative colitis

Most common reasons in grants

  1. Current diagnosis established21
  2. Moderately severe symptoms with frequent exacerbations5
  3. Ulcerative colitis rated under DC 73233
  4. Pronounced symptoms with marked malnutrition, anemia, general debility2
  5. Severe symptoms with numerous attacks per year2
  6. Private physician opinion found persuasive2
  7. Marked malnutrition, anemia, general debility2
  8. Caused by the service-connected disability2

Most common reasons in denials

  1. VA examiner: less likely than not related to service31
  2. Preponderance of the evidence against the claim30
  3. No in-service complaints, treatment or diagnosis27
  4. Service records negative or silent24
  5. No current diagnosis21
  6. Current diagnosis established16
  7. Ulcerative colitis rated under DC 73238
  8. No nexus to service3

Numbers are decisions that gave the reason. Reasons are short phrases extracted by AI from each decision; common wordings of the same reason are grouped. Benefit of the doubt is reported above.

Recent ulcerative colitis decisions

Granted

Citation Nr. A26038715David Gratz · 2026

Veteran's Crohn's disease rated 30% under DC 7323 (ulcerative colitis, moderately severe symptoms); 60% rating warranted for severe symptoms with numerous attacks and malnutrition; No marked malnutrition, anemia, debility, or serious complications found to warrant higher rating

Citation Nr. A26025759Anthony C. Sciré, Jr · 2026

Evidence evenly balanced for 60% rating; Managed with biologic agent (Humira); Recurrent abdominal pain and diarrhea episodes

Citation Nr. A26024766E. I. Velez · 2026

Private treatment records show treatment with prednisone for flare-ups, symptoms of pain, bleeding, and diarrhea.; Veteran reported 3-10 bowel movements per day during flare-ups, and was unable to leave the bathroom.; Private provider noted anemia based on bloodwork, which the Board found persuasive despite VA exam not finding anemia.

Denied

Citation Nr. A26039520A. P. Simpson · 2026

VA treatment records and examinations from October 2020, April 2021, and July 2022 were found most probative.; Evidence did not consistently support severe symptoms with malnutrition and numerous attacks.; October 2020 and April 2021 VA examiners found no weight loss or malnutrition.; September 2022 VA review of systems was negative for fatigue, fever, sweats, chills, and unexplained weight changes.

Citation Nr. A26034947R. Feinberg · 2026

Service treatment records silent as to ulcerative colitis.; VA examiner opined less likely than not related to service.; No medical evidence links TERA to ulcerative colitis.; Veteran's lay opinion on etiology not probative.

Citation Nr. A26032189L.M. Yasui · 2026

No gastrointestinal complaints or treatment in service treatment records.; Separation examination normal for gastrointestinal issues.; No evidence of in-service onset or nexus to service.

Rules that apply to ulcerative colitis claims

Research your ulcerative colitis case

Narrow by year, judge, evidence or secondary condition, read the decisions, and export a research memo.

Open VA Law Explorer

How these numbers are calculated

  • Rates count decisions in which the Board decided a ulcerative colitis issue, by the outcome of that issue. Other issues in the same decision can have different outcomes.
  • “Granted on the merits” leaves out remands and dismissals. “All conditions” is the grant share across every condition issue in the data.
  • The data comes from CaseScribe's AI extraction of public BVA decisions (2018–2026) and can contain errors. It is updated automatically as new decisions are added.